AG

RandomGenerator_1

This company is so much more than the little piece you posted here. It's a treat to research it further, so give it a go. You have their Defense department. But the products Palladyne Pilot and Palladyne IQ have way more potential. Pilot already is partnered with Red Cat - RCAT and Draganfly - DPRO. If we go further, RCAT is partnered with Aerovironment and Redwire to integrate and this swarm with their products. Palladyne is the swarming partner and the only company to bring true swarming to the US (letting the drones reason on their own and "retrain" on the fly. Adjust in real time to what other drones are doi g in whatever environment they are in.) They have a patent to be the brain of the network of sensors. Think of all the sensors out there, on drones ,on robots, camea's, ground vehicles .. that combine data for a human to take a decision. They have been adding heavyweights to the team, where the keywords are: F-35's, Anduril's Fury, Iron Dome. And that's just for defense and public safety. They also work for manufacturing. Focussing on the Automative industry, among many other things. And end of July 2025 they were invited at the Kuka Robotics showcase. (Kuka is used by automotive manufacturers such as BMW, GM, Chrysler, Ford, Volvo, Volkswagen, Daimler AG and Valmet Automotive, as well as by manufacturers from other industrial sectors such as Airbus, Astrium and Siemens.). And PDYN IQ is also being tested on robots from ABB (soon to be Softbank) and Fanuc. And Universal Robots - Cobots. They also added a board member from Caterpillar.m recently. TAM IQ: 500 000 industrial robots each year - adds to million of robots that are already in place. PDYN can retrofit existing robots and help sell new robots for applications ppl didn't think they could be used for. TAM Pilot: new market. Drones are estimated to become a multibillion dollar market. This company was the robotics pioneer,.next to Boston Dynamics. They travelled a long sucessful road and have extensive experience, which brought them to a unique solution to be the brain for Physical "embodied" AI.

NeetoBurrritoo

AG was supposed to comment on all the black lines in the documents so we needed to stock up on more black ink

pink_ego_box

CDE AYA AG NEXA SBSW ARMN SIL SILJ GDX GDXJ A few lottery tickets (explorers) TUD VSO Staying away from Hycroft andHSLV because of some experts' opinion on their overvalued assets

pink_ego_box

ETFs SIL SILJ Individual stocks AYA AG PAAS CDE NEXA

RequirementNo3067

Personally my strategy has been selling puts in gold/ silver mining companies. Gold and silver are in a crazy bull market rn and I do expect it to continue well into this year. The mining companies I believe are undervalued and the ivx is extremely high on them plus most are lower priced so being cash secured is easy. I've been selling weekly puts on a Monday and Tuesday on ticker AG (First Majestic) at a strike just outside the expected move and have been just letting them expire worthless or roll out to the next week. Has worked well for me this past year. The margin req for that ticket is only like 250$ a contract too. Very liquid.

Retired-Programmer

Back in 2000 timeframe I sold some property and had some extra cash and started investing. Can't remember how but I got contacted by a financial guy with AG Edwards and he convinced me to move my funds to AG Edwards and he would manage my accounts. I remember a few months in him vividly telling me the internet boom is here to stay (meaning these gains in the stock market aren't going away). Then I needed some money to pay the taxes on the gains I got from selling the property so I got the money from that AG Edwards account but the AG Edwards financial guy convinced me to not sell any of the stocks and to go on margin (TBH, didn't take that much convincing to get to do do it). Sometime later (a few months maybe, can't remember exactly) my account was down 80% (and there wasn't that much being used in margin, it was also just losing so much in the stocks as well). In the end after some recovery I think I was down something like 50% overall from what I started with and have since recovered (after many years and adding my own money in my accounts). I don't totally blame the AG Edwards financial guy because if I had done it on my own not sure it would have been much different (although I probably wouldn't have gone on margin on my own because I probably wouldn't have even known about margin). So what I am trying to convey is, you better know what you are doing if you use margin. Margin works great when the stock market goes up like it has been doing for the past 6 years, but can be devastating when it doesn't. If you can spread out the conversion of stocks to cash over separate years and it prevent you from going to a higher tax bracket then that would be worth it. But my main point is, I would stay away from margin.

TheHawk1313

A question... Why have Morgan Stanley, Susquehanna Intl grp, UBS Group AG, and EverSource Wealth Advisors all sell 100% of their holdings between 11/10 and 11/14 '25 ?

Worried_Quarter469

Rheinmetall AG (RHM.DE) might get hot again

MatrixOrigin

Lmao ok so a few posts here and there with minimal supporting comments about the subject... Does that mean "this sub is convinced Trump will legalize cannabis"? Regarded as I said. As for progress... Trump signed an executive order to get things moving... Why did Biden's AG and DEA stall for 2 years? Do you not remember ?[ALJ calling them out](https://x.com/JoeCool_15/status/2007137236257759406)

dinanm4

Glad I bought an assload of SILJ and AG

Hey_Hank

Could BAT be considered big AG? BAT is the money and driving force behind the Phylos move by OGI. Especially the THCV strains. BAT is also a very big investor in CWEB. I say this in a very good way as BAT was without a doubt the most ethical, and best marketers in the tabacco business that I ever worked with.

ConversationLazy9190

$AG getting railed. It’s almost like they don’t sell silver 🤦‍♂️

Asleep_Adagio3756

Monsanto was the worst. They were bought by Bayer AG. So now they are the worst. BAYRY

BassLB

GEO is the one that trumps AG Pam Bondi was a lobbyist for. They have spiked a bunch since the new admin and have won new federal contracts. Complete coincidence I’m sure.

Safety-International

It’s relatively large for the space yes, you don’t need tiny miners to make money. Even AG should be not at 1:1 with spot price

Good-Tiger-1938

Bayer AG (German chemical giant, owns MONSANTO, created Agent Orange)

Jumaruss

Bayer AG? (bought Monsanto in 2018)

yea-uhuh

Doesn't look like game stop, yet. Trump EO says "hemp" needs to be unbanned. Short positions from Dec 18 are still a decent bet. AG Bondi unlikely to finish S3 before Congress is pushed to correct the 2026-impending hemp ban. Easiest remedy is kick the can, revert to 2018 hemp definition. McConnell unintentionally passed the ban on CBD cultivation, before the medicare CBD $500 announcement. Botony is a bitch for politicians to comprehend, these plants all produce a bunch of THCA before they yield any CBD. USDA fully understood the implications of 0.3% delta-9 in 2018, sucessfully excluded mind-bending sticky-icky from hemp farming.

MarthaJulietta

Really loving VITL performance this week. Chart is looking really nice. Still a long way off but every day brings earnings closer and I dont think the stock will stay in the low 30s before that reading comes out. I dont have the courage to add on any more (I did buy another 6 calls on the 22nd) but I'm feeling real good about things. Also started buying their eggs even though the idea of $9 eggs is crazy to me. Every little bit helps if we do have to hold through earnings. Little note- they do do some cool stuff- there is a QR code on the carton I can scan to read about the exact farm the eggs came from and watch a video of the chickens in their pasture. Very cool if you are ethically opposed to AG practices and animal wellbeing PYPL on the other hand is suffering but again I think the buybacks + divi + growth makes this a no brainer over the mid term and I have continued to add Jan 28 calls every day its under $60. Up to 43 $35 calls now and will continue to add until I cant anymore

MarthaJulietta

Really loving VITL performance this week. Chart is looking really nice. Still a long way off but every day brings earnings closer and I dont think the stock will stay in the low 30s before that reading comes out. I dont have the courage to add on any more (I did buy another 6 calls on the 22nd) but I'm feeling real good about things. Also started buying their eggs even though the idea of $9 eggs is crazy to me. Every little bit helps if we do have to hold through earnings. Little note- they do do some cool stuff- there is a QR code on the carton I can scan to read about the exact farm the eggs came from and watch a video of the chickens in their pasture. Very cool if you are ethically opposed to AG practices and animal wellbeing

suprfreek19

Scratching my head as to why everyone thinks Trump rescheduled weed. He issued an EO. The AG is the person with the authority to reschedule, not the president. An anti-weed AG!

1dayremains

Jon AG if yk yk

PenguinnBets

I am in. This stock is seriously undervalued but they have to show how their business model can benefit shareholders. Also the really small float will be hard for major institutional investor participation. However, there are some already have a foot at the door. Here is the Q2 to Q3 changes in holdings. Would be interesting to see the Q4 numbers: |Institution|2025-Q2|2025-Q3| |:-|:-|:-| || |GEODE CAPITAL MANAGEMENT, LLC|28383|33582| |RENAISSANCE TECHNOLOGIES LLC|11277|27377| |VANGUARD GROUP INC|27012|27012| |XTX Topco Ltd|22671|19612| |UBS Group AG|23942|17556| |TWO SIGMA INVESTMENTS, LP|0|12254| |BlackRock, Inc.|8607|8607| |Tower Research Capital LLC (TRC)|3646|4509| |CITIGROUP INC|642|295| On the other hand, the small float is perfect for retail investors to take control collectively.. lol. Maybe someone here can consider to create a sub for this.

PenguinnBets

Nice call. I am in as well but at higher level. This stock is seriously undervalued but they have to show how their business model can benefit shareholders. Also the really small float will be hard for major institutional investor participation. However, there are some already have a foot at the door. Here is the Q2 to Q3 changes in holdings. Would be interesting to see the Q4 numbers: |Institution|2025-Q2|2025-Q3| |:-|:-|:-| |GEODE CAPITAL MANAGEMENT, LLC|28383|33582| |RENAISSANCE TECHNOLOGIES LLC|11277|27377| |VANGUARD GROUP INC|27012|27012| |XTX Topco Ltd|22671|19612| |UBS Group AG|23942|17556| |TWO SIGMA INVESTMENTS, LP|0|12254| |BlackRock, Inc.|8607|8607| |Tower Research Capital LLC (TRC)|3646|4509| |CITIGROUP INC|642|295| On the other hand, the small float is perfect for retail investors to take control collectively.. lol. Maybe someone here can consider to create a sub for this.

thinkneo

Smart approach. picking the winning robot company is a crapshoot, but they all need components. The actual supply chain breakdown: Precision reducers/gears (this is the niche monopoly): \- Harmonic Drive (Japan: 6324.T) and Nabtesco (Japan: 6268.T) control \~75% of the precision gear market for robot joints. every robot arm needs these. extremely hard to replicate - takes years of manufacturing expertise. closest thing to a monopoly in robotics. Servos/motion control: \- Yaskawa (Japan: 6506.T) - largest servo motor manufacturer globally \- Fanuc (Japan: 6954.T) - dominant in industrial robots AND makes their own servos \- Rockwell Automation (ROK) - US play on industrial automation \- Parker Hannifin (PH) - motion and control systems Machine vision: \- Cognex (CGNX) - dominant in industrial machine vision. high margins, niche leader \- Keyence (Japan: 6861.T) - sensors, vision systems. insanely profitable, 50%+ margins Lidar/sensors: \- this space is crowded and bleeding money. Luminar, Ouster, Hesai all struggling. I'd avoid until there's a clear winner \- Sick AG (Germany) is the boring profitable option for industrial sensors Chips: \- NVDA for AI training and edge compute (Jetson platform is popular in robotics) \- AMD growing in data center, also has embedded solutions \- Qualcomm (QCOM) for mobile/edge robotics \- Texas Instruments (TXN) and Analog Devices (ADI) for the less sexy but essential motor control chips The picks I'd actually consider: 1. Harmonic Drive or Nabtesco (duopoly on precision gears) 2. Cognex or Keyence (machine vision, actual moats) 3. Rockwell or Yaskawa (automation exposure)

Internal_Field5970

Some of you order AG1 with a Joe Rogan promo code and it shows 

AverageNo130

If that is their path there will be a new DEA Chief and personnel. And a new AG if she's involved imo. Garland should have been fired along with the DEA entrenched obstructionists. imo Trump is trying to find out what is going on by pressuring the DEA/DOJ with the EO if continue delays.

wendyxdxd

$AG a great silver mining company. Silver and $AG to the moon in 2026 💰🚀 🌙

BanAccount8

AG

eastcoastsomeone

AG calls.

yea-uhuh

AG Bondi wants to raid every dispensary nationwide ? That's what S3 actually means. She might go further, if she is smart.

w41t3rpwnZ0RZ

Under the Controlled Substances Act, the authority to reschedule substances via the executive branch belongs to the AG. Historically the AG has delegated it to the head of the DEA, but they are not obligated to do this. Source: https://www.congress.gov/crs-product/R45948#fn84 If you believe Bondi does whatever Trump says (I do), then S3 is very likely to happen. Great time to buy!

-ThatThomasGuy-

I'm holding a few of the producers. EXK, PAAS, and AG and thry have worked wonders for me this year.

-ThatThomasGuy-

As crazy as it sounds, hard assets. I am looking at SLV, as well as gold and silver miners. I hold EXK, PAAS, and AG as my bigger positions right now.

Retintintin

AG1! Futures for silver on SHFE is up over 5.5% today, currently standing at a 10% premium compared to yesterdays COMEX close

Dr_Phil_Has_A_Huge_D

Israel doesn't want you to remember that their citizen Sigal Chattah, who is still inexplicably the US AG for Nevada (even after being ruled invalid by US federal judge)...released fellow Israeli, and a government agent, who tried to f' a kid in Vegas...specifically to flee US to Israel. is Tom Alexandrovich. Pic: Chattah https://preview.redd.it/3wxhn5br1j9g1.jpeg?width=500&format=pjpg&auto=webp&s=af477adcb16a14737bc2b898f0678df7763756be

bomusaab

$AG First Majestic.. their high exposure to silver mining + price of silver (silver deficit and criticality of it is pushing prices up) + the fact that it is still lagging + their low all in sustaining costs (it costs them $20/oz to mine and look at silver price, margins are crazy) = 🚀

daddyspain69

Auto1Group (AG1 on Frankfurt exchange. European Carvana with no corporate debt and insane EBITDA growth. I’m up 350% since getting in at 6€

kaapooj

honored to meet the AG

Mrvonblogger

No, but AG1 gives me the messiest green poo’s on earth. Seriously, why the fuck do people buy this supplement

shooterdoobydoo

Grabbed AG back in 21 at 1.44. Still got it and now there’s supply constraints on physical metals so don’t see it stopping

Puzzleheaded-Monk688

$JD $ONDS $UP $AG, played some spy calls and a few other tickers like $UPS and $BABA but those were the big ones

suprfreek19

How about a “slow walk” from an AG who is non 420 friendly? What would that timeline look like?

mr_molecular

Here is how this could play out. The "Expeditious" Path: Strategy and Timeline The administration's most likely path involves the Attorney General exercising her authority to bypass the DEA's stalled administrative hearings. Phase 1: Bypassing the Hearing (December 2025 – January 2026) • Action: The Attorney General (AG) can conclude that the administrative record—which already contains over 42,000 public comments and a comprehensive scientific review from the HHS—is sufficient to make a final determination. • Legal Basis: The AG may argue that a formal hearing is "unnecessary" or that the public interest in medical access outweighs the need for further oral testimony, especially since a federal judge already suspended the previous hearings in early 2025. • The "International Treaty" Shortcut: Legal experts suggest the AG could cite 21 U.S.C. § 811(d)(1), which allows for expedited scheduling to comply with international treaty obligations, bypassing the standard hearing requirements.  Phase 2: Drafting and OMB Review (January 2026 – February 2026) • Drafting the Final Rule: The DOJ and DEA would draft the "Final Rule." This document must address the major concerns raised in public comments to be legally "defensible" against future lawsuits.  • OMB Review: The Office of Management and Budget (OMB) must review the economic impact. Under the Executive Order, this review would likely be fast-tracked to a matter of weeks rather than months. Phase 3: Publication and Effective Date (March 2026 – April 2026) • Publication: The Final Rule is published in the Federal Register.  • Cooling-off Period: Usually, a rule takes effect 30 to 60 days after publication.  • Final Result: By April 2026, marijuana would officially be Schedule 3.

skyplt29

I appreciate the Marijuana Herald is not known for its accurate accountings...but this does fit with Dr. Oz suggesting Medicare support by April. I will be seeking out a more credible source and will share if I find anything: "President Trump has directed Attorney General Pam Bondi to issue a final ruling on marijuana rescheduling by the end of January, according to two sources close to the president who spoke with The Marijuana Herald. The executive order signed by Trump last week orders AG Bondi to “take all necessary steps to complete the rulemaking process related to rescheduling marijuana to Schedule III of the CSA in the most expeditious manner in accordance with Federal law”. Under federal law, any rescheduling decision must be finalized through DOJ, with coordination from the Department of Health and Human Services (the Department issued their rescheduling recommendation in 2023). Trump’s message to Bondi, as described by the sources, underscores that while the administration intends to follow the legal framework, it also expects a timely outcome rather than prolonged administrative delays. Although Trump ordered Bondi to issue a ruling “by the end of January”, it’s possible a ruling could come early in the month. If DOJ follows through with issuing a final rule on an accelerated timeline by the end of January, marijuana would be officially moved to Schedule III by the spring, a change that would formally acknowledge accepted medical use under federal law and significantly alter how the substance is treated for tax, research, and regulatory purposes. Schedule III status would not legalize marijuana federally, but it would eliminate the punitive tax provision known as 280E, expand opportunities for scientific research, and allow FDA-approved cannabis medicines to be prescribed nationwide (currently only CBD and synthetic THC can be prescribed). The push for a January deadline comes as pressure continues to build from lawmakers, industry stakeholders, and patient advocates who have been awaiting clarity since the rescheduling review began. A final ruling will mark the first change to marijuana’s federal classification since it was placed in Schedule I more than five decades ago. While DOJ has not publicly commented on the timeline, the president’s position suggests the administration wants the matter resolved quickly, setting the stage for a major shift in federal marijuana policy at the start of the year."

Simplylegalize

A bit of schedule 3 talk? He signed an executive order asking the AG to expedite schedule 3. Trump has always been negative on recreational cannabis, that position has not changed. If you thought he was going to do anything positive about recreational cannabis, you obviously haven't been paying attention. The biggest deal as you alluded to is that schedule 3 is not finalized yet and could take 6-12 more months

suprfreek19

What comes next is waiting for it to actually be rescheduled. Only the AG can do that. An EO from the president is not a reschedule. Sorry folks but you’ll have to be patient.

w41t3rpwnZ0RZ

I do buy your explanation about people getting too excited about news before it drops, in general. I think we disagree about the nature of the news— in my mind this does more or less live up to the hype. There was never any scenario where the EO directly rescheduled marijuana, the president doesn’t have that authority. And directing the AG (not the DEA) to issue a final ruling as soon as possible (and specifying the direction of the final ruling), is IMO as much as the EO could reasonably be expected to do. I have done some amount of looking at the books, so to speak, but admittedly mostly via youtube videos/reddit comments that could be biased. That being said I have seen the difference that 280E makes and it looks massive (to me, an amateur). Anyway, you seem right for now! I’m gonna keep holding and see what happens.

illinformed-will

HL, PAAS, ASM, AG top pick. USAS SVM DVS risky. SBSW NEWP proxy with other metals. When spot silver hit 75 there might be a correction before pumping resume, hedge accordingly.

suprfreek19

Waiting for anti weed AG to complete the job.

suprfreek19

This is true. Add to that an AG who is NOT 420 friendly.

MilesRover1974

This still does not change the fact that he did exactly what he said he was going to do....order the AG to move to schedule 3. I don't believe he has the power to actually reschedule on his own. Adding banking reform would have been super duper amazing and I would have loved that move as much as the next guy, but that was never promised, just rumored. Don't get me wrong, I'm in no way a Trump fan, but what his put into motion is the most positive move that this space has seen in decades. Good luck to people in support of this move. To the prohibitionist...I hope you get coal for Xmas.

suprfreek19

We still don’t have a reschedule, only an EO directing the AG (Bondi) to expedite rescheduling.

Suitable_Reality_138

$RDDT more $TSLA, $WLDN and more $AG. Great composite ratings, except $TSLA but robotics theme story is strong enough that it’ll likely bring that up.

King_Chron

**Trump's Executive Order: What Actually Changed** **The Direct Push:** Trump's order explicitly directs AG Pam Bondi to complete rescheduling in the "most expeditious manner" - legal experts call it a "big push forward" that uses presidential weight to override bureaucratic delays that stalled Biden's 2022 initiative. **Why This Is More Decisive Than Biden's Approach:** * Biden (2022): Launched multi-agency review dependent on HHS/DEA cooperation - criticized for slow pace * Trump (2025): Direct mandate to finalize existing proposal, treating it as priority vs. continued "study" * Biden-era process stalled by mandatory hearings (originally Jan 2025) and 43,000 public comments creating procedural pauses **Policy Framing Shift:** Trump frames it as "common sense" backed by 82% public support, explicitly stating "facts compel federal government to recognize marijuana can be legitimate for medical applications" - removing the federal position that cannabis has no accepted medical use. Unlike Biden's broader "equity" focus, includes targeted programs like Medicare pilot reimbursing seniors up to $500 annually for CBD (starts April 2026). **Immediate Industry Impact:** * **Taxation**: Schedule III eliminates IRS 280E penalty preventing state-legal businesses from deducting expenses (rent, payroll) * **Banking/Investment**: Expected to push Nasdaq/NYSE to reconsider listing U.S. cannabis companies and advance SAFER Banking Act **Bottom Line:** Order strategically timed for immediate financial relief and uses executive pressure to clear bureaucratic backlog.

King_Chron

\- **Trump's Executive Order: What Actually Changed** **The Direct Push:** Trump's order explicitly directs AG Pam Bondi to complete rescheduling in the "most expeditious manner" - legal experts call it a "big push forward" that uses presidential weight to override bureaucratic delays that stalled Biden's 2022 initiative. **Why This Is More Decisive Than Biden's Approach:** * Biden (2022): Launched multi-agency review dependent on HHS/DEA cooperation - criticized for slow pace * Trump (2025): Direct mandate to finalize existing proposal, treating it as priority vs. continued "study" * Biden-era process stalled by mandatory hearings (originally Jan 2025) and 43,000 public comments creating procedural pauses **Policy Framing Shift:** Trump frames it as "common sense" backed by 82% public support, explicitly stating "facts compel federal government to recognize marijuana can be legitimate for medical applications" - removing the federal position that cannabis has no accepted medical use. Unlike Biden's broader "equity" focus, includes targeted programs like Medicare pilot reimbursing seniors up to $500 annually for CBD (starts April 2026). **Immediate Industry Impact:** * **Taxation**: Schedule III eliminates IRS 280E penalty preventing state-legal businesses from deducting expenses (rent, payroll) * **Banking/Investment**: Expected to push Nasdaq/NYSE to reconsider listing U.S. cannabis companies and advance SAFER Banking Act **Bottom Line:** Order strategically timed for immediate financial relief and uses executive pressure to clear bureaucratic backlog.

King_Chron

no, the EO tells the AG to get the mess straightened out so that the hearing can take place as its been in appeals since jan2025 when it was suppose to happen.

AmDazed

I feel your pain. The reason we saw a "sell the news" event today is exactly because the market hadn't accepted this as a foregone conclusion. Between the terrible mainstream reporting and the PTSD from the Biden delays, most people were still treating this as a "maybe." They sold today because they reached their "confirmation" exit point. But you’re onto something with the upcoming announcements. There is a huge difference between selling a rumor that might be fake and buying a reality that has been officially digested. When news is already accepted and "predigested" by the smart money, the actual announcement usually causes a boost, not a sell, because it officially removes the "risk discount." Think of it this way: Today was a shakeout because the market was surprised by the speed. But moving forward, as we hit milestones like the Federal Register publication or the actual dark black ink on the 10-Qs, the "rumors" will be about specific dollar amounts and analyst upgrades. Once the market finally accepts that the 280E wall is gone, the confirmation of those events becomes a tailwind, not a reason to exit. We're moving from the "Hype" phase to the "Math" phase. By the way, these processes are already completed or no longer relevant: * **Public Comment Period:** Closed. The DEA already collected the 43,000 comments in 2024. * **DOJ Alignment:** Resolved. Today’s EO removes the friction between agencies and directs the AG to finish. And these are the milestones that will likely move from speculative rumors to confirmed boosters: * **Federal Register Publication:** This is the big one—it triggers the final countdown. * **Analyst Model Updates:** When the banks flip their spreadsheets from 80% taxes to 21%. * **Institutional Re-entry:** When major funds finally have the "legal" cover to buy. * **MSOS Inflows:** As 280E dies, the cash flow makes the ETF a fundamental play, not just a trade.

AmDazed

Actually, this is one of those times an EO actually can do what it says. It isn't starting something new; it’s directing Pam Bondi to complete a process that Biden started that got stalled in bureaucracy. The HHS medical review and the 43,000 public comments are already 100% finished and part of the legal record. All that’s left is for the AG to sign the Final Rule, which she’s legally allowed to do and will obviously be happy to do for Trump to get him a 'Day 1' win. Once she signs, the 280E tax barrier falls automatically. We aren't waiting for a study or a review; we're just waiting for Bondi's signature.

AmDazed

Actually, this is one of those times an EO actually can do what it says. It isn't starting something new; it’s directing Pam Bondi to complete a process that Biden started that got stalled in bureaucracy. The HHS medical review and the 43,000 public comments are already 100% finished and part of the legal record. All that’s left is for the AG to sign the Final Rule, which she’s legally allowed to do and will obviously be happy to do for Trump to get him a 'Day 1' win. Once she signs, the 280E tax barrier falls automatically. We aren't waiting for a study or a review; we're just waiting for Bondi's signature.

Ok-Replacement9595

Because it can be the DEA or the AG. Garland was an awful AG, but he did sign off on the change to schedule 3 already, which was going through the legal process of an ALJ to make sure all the check boxes were checked and the process was fair and true, when orange man was elected and everything was halted. This is just a presser to try to buy votes, like the veteran checks and the farmer checks, and hopefully the healthcare checks to come. Guy is losing the midterms and knows it, and that is without the slow drip of Epstein revelations about his love affair with children.

Ok-Replacement9595

That is wrong. It can be done through congress or through DEA or AG. You can actually Google the CSA in your spare time.

AmDazed

She *could* wait, but why would she? This isn't a holdover from the last administration that she’s reluctantly finishing—today's EO effectively 're-branded' rescheduling as a Trump/Bondi priority. Here is why the signature is likely days, not months away: 1. **The 'Common Sense' Branding:** The President just stood in the Oval Office and called this 'common sense' for veterans and seniors. Bondi isn't going to let that headline go stale by sitting on it for 90 days. 2. **Administrative Cleanup:** The EO specifically directs her to 'cancel' the stalled Biden-era hearings. That was the only legal logjam. Since the 43,000 public comments and the HHS medical review are already in the bag, the 'work' is done. 3. **The Hemp/CBD Tie-in:** The EO also links this to Medicare coverage for CBD (starting April 2026). For that to work, the rescheduling needs to be finalized now to clear the legal path for the HHS to build those research models. In the cannabis world, we're used to 'Soon', but this is the first time we’ve had a President and an AG on the same page with a direct order to 'expedite and complete.'

Tiaan

The main reason why we're dropping so hard is that rescheduling has not actually happened yet. The media is acting like it's already done with headlines "EO to reschedule cannabis" and the administration is acting like it's already done with language like how significant this is, etc, similar to what the Biden admin did where they acted like they actually changed marijuana laws without actually finalizing rescheduling Executive orders are legally binding within the executive branch. This was Trump's order to the AG in the EO: > The Attorney General shall take all necessary steps to complete the rulemaking process related to rescheduling marijuana to Schedule III of the CSA in the most expeditious manner in accordance with Federal law, including 21 U.S.C. 811. While its hugely positive that this EO indicates rescheduling will happen, the language doesn't provide any definite timeline and "rulemaking" specifically can take months or longer. Everyone who is taking this as "wow I guess rescheduling wasn't that significant or impactful" is also acting like it's been finalized, which it hasn't. I'm hoping the final rule will be issued within the next 6 months but I despise this sector so god damn much and just want it all to end already

AverageNo130

The AG will respond in the affirmative or she's out.

suprfreek19

I might be wrong but today’s action was an executive order. The Controlled Substances Act calls on the AG to reschedule. Thoughts?

Resi86

I think people are mistakenly viewing this as a repeat of the timeline that Biden already covered. No, the HHS will not need to make a new recommendation, he simply states that the AG will expedite the completion of the rescheduling process. I see how some view this as an indefinitive and uncertain timeline, but I view it as getting done in the near term, but at the latest with ample time leading up to the midterms. I don’t believe the GOP would campaign on this issue though, so it wouldn’t make sense to leave it till the midterms.

volckerwasright

He cannot reschedule via EO, directing the AG/DEA head to sign a Final Rule is the only mechanism available.

UsedState7381

EO leaked on Marijuana Moment. Details: Orders the AG to finalize the rescheduling process to schedule 3. No details on Safe Banking, no details on Uplisting. >Direct the attorney general to expedite the completion of the process of rescheduling marijuana to Schedule III of the CSA. >Direct top White House staff to work with Congress to give patients access to full-spectrum CBD products, “while still restricting the sale and access to products that cause serious and potentially life threatening health risks.” >Urge Congress to examine updating the definition of hemp to ensure that full-spectrum CBD is accessible to patients—a policy change that could mitigate some concerns in the sector about a recent spending bill Trump signed with provisions that would broadly ban consumable hemp products. >Direct the U.S. Department of Health and Human Services (HHS) to “develop research methods and models, to utilize real world evidence [and] to improve access to hemp-derived CBD products in accordance with federal law” while informing “standards of care.” >Separate from Trump’s order, Mehmet Oz, administrator for the Centers for Medicare & Medicaid Services (CMS), will also be announcing “a model that will allow a number of CMS beneficiaries to benefit from receiving CBD under doctor recommendation at no cost,” the White House official said. Not everything about the EO has been leaked, but I would NOT assume it's much beyond this. Brace for dips.

ivigilanteblog

> I could very much see a scenario where the EO is “I’m forcing congress to look at this”  He can't *force* Congress to do much of anything, but this is sort of what I'm hoping for. Our best-case scenario, which is incredibly unrealistic IMO, is just a direct order to the AG to deschedule cannabis, permitting time for Congress to update related laws and the FDA to issue regulations. The stocks will go absolutely nuts if this happens, because nobody expects it. Our best-case *realistic* scenario is basically what you said: an executive order to reschedule to S3 and a statement that he either wants Congress to look into descheduling/legalizing, or a statement that he is forming a descheduling commission of sorts to propose rules for that purpose. I give this decent odds, but I'm not confident he'll take it this far. Our most realistic scenario is that he will just order the AG to continue the process of rescheduling to S3, bypassing the DEA process (which is *not* mandatory, since Congress delegated the authority to schedule drugs to the AG; they have just traditionally deferred to DEA and, more recently, the combined recommendations of HHS and DEA). Our worst-case scenario, other than absolutely nothing occurring, is an order that does something like reschedule to S2. We'd likely crash as a result.

Happy-n-Healthy

Call your State AG

ThanksS0muchY0

Honestly I was pretty VOO and chill til this year. I'd been following market news for several years, tries my hand at day trading, saw better returns on my set and forget funds, and sold everything and opted for almost 100% VOO for a couple years. Then in February I had clammy hands and decided to sell half of it and invested that in Rheinmetall AG and Rolls Royce. Sold half of them off and put it back in VOO. Proud of myself, I kept about 20% out to start day trading again. That has also proven fruitful, barely escaping the rare earth hype with over 50% gains in only a couple months. My savings accounts are huge, and I have as much money to day trade with as I did total at the start of the year. I haven't added anything from my paychecks since the end of January, and that extra cash every month has been great for the family. Now, with only about 5% gains on options since October, I'm debating putting it all back into VOO so we can chill. Maybe the president will gift us another skyrocketing VIX with clearcut signals, but I still chalk it up to dumb luck.

CalTechie-55

The way I pick tickers is: I have BarChart email me a list of tickers with weekly option where 100% of its technicals (MA crossovers) are signaling 'Buy'. Then on the weekend, I construct a quality factor 'Q' for each one: the bid for the nearest weekly put divided by its strike * 52, giving the maximum annualized return for selling that put. I select the 5 or 6 top payers, and sell enough weekly contracts on Monday to bring in my desired weekly credit. If a put gets too far ITM I may roll down & out during the week. Otherwise, I don't sweat assignments, since in these 100%Buy stocks, I can usually depend on making a profit on the call. This week I picked AG,APP,FN,LABU,TER, & WDC. Q's ranged from 113% to 206%. I haven't kept track of profits, but a 5 year backtest of weekly ATM SPY wheels was profitable every year.

UnclePsilocybe

Some of them pay an upwards of 70% in taxes. They also can't write off hardly any business expenses. Profitability would be immensely helped by S3 and removal of 280E. Pam Bondi has the authority as US AG to reschedule. Historically the AG deferred the decision to the DEA, who said no. I'm interested in the language of the EO. If Trump directs the AG to reschedule then I think it has a good shot. If I read some BS like, "Begin the process of evaluating S3 status" then it ain't going nowhere. 

Dolancorp

The sun crests the horizon and enters the window of your Trump Towers apartment. You awake to birds chirping as you remove your AG1 IV drip from your belly button. Rolling out of bed in your lululemon onesie, you turn on the news. Joe Rogan's voice fills the room explaining that Baron Trump has won the U.S. presidential election. You check your phone to see Gamestop at $10,429.12 per share.

Ok-Replacement9595

I said DEA director can make the final rule, or the AG. Then by statute the recvomendation heads to congress for hearings (but honestly i havent read the statutes for years). The president, in any rational administration has no role. But half the country assumes this is a monarchy and long for tyrannical retribution on the rest of us for their idiocy.

rockum

An EO isn't needed to order the DEA head and AG to issue a final rule. Whats weird is that the meeting he had on Wednesday didn't include the DEA or AG. From the newsweek article: > Per the outlet, Trump discussed the plan on Wednesday with House Speaker Mike Johnson, Health Secretary Robert F. Kennedy Jr and Centers for Medicare and Medicaid Services chief Mehmet Oz, as well as marijuana industry leaders, over the phone from the Oval Office. This whole thing is kinda weird which is one reason I've been skeptical.

GingerSnapSurprise

Those industries and the defence industry as a whole can be volatile, so definitely do your research, diversify, etc. Small arms specifically is a fickle industry, and very much feast or famine depending on individual contracts. That said, I do agree with you on the general outlook given the state of the world. Personally I would look into some of the more diversified and established defence contractors. Olin is a decent choice, and is well established (if not always having rapid growth). I would also look at: - Rheinmetall AG - One of Europe's largest defence contractors - Have seen insane growth since 2022 (seriously, look at the chart) - Lots of new investments and contracts in the pipeline - Everything from tanks/AFVs to artillery shells to flashlights - BAE Systems - Has absorbed many of the historic UK and European defence companies (Hawker, Vickers, Hadley-Page, Bofors, Yarrow shipbuilders, etc.) - UK's only nuclear submarine builder - Also does avionics, radar, air defence, Naval and AFV guns, guided anti-tank weapons, etc. - Lockheed Martin - F-35, the only currently produced fifth-gen fighter for NATO/aligned contries - unfortunately many countries have put off new aircraft (in this case fighter) acquisition/development for so long that the F-35 remains the only choice if they want a viable replacement fleet in the next decade - precision munitions (e.g. Hellfire, Javelin, Patriot), Sikorsky helicopters, radar, bunch of other things - General Dynamics - Tanks, AFVs, US nuclear submarines - Let's not talk about Ajax though - Teledyne - bunch of stuff, but they recently acquired FLIR, which is one of the best thermal optics manufacturers My fingers are getting tired, and there's a bunch of others like: - L3 Harris - Elbit - Airbus - Rolls-Royce (jet engine or nuclear reactor divisions) - Raytheon - Saab (Grippen fighter among other things) And more

Tiaan

If Trump issues the EO Monday ordering his DEA head and AG to issue the final rule, it will confirm that the intentions of his administration are to reschedule cannabis. That in itself will dispel a lot of the FUD surrounding this issue imo The question would then become "when do DOJ/DEA actually issue the final rule?" IMO this part could happen months later, likely by summer 2026. I'd expect we retrace some in between the EO and the final rule actually getting issued

Tiaan

There's a lot of confusion around this. The president cannot reschedule by EO directly. The people with legal power to reschedule via the administrative rescheduling process are the DEA head and Attorney General. They both work for the president. The EO will be directing the DEA head and AG to issue a final rule for the currently ongoing rescheduling process that began under Biden back in 2022. The only reason why Trump is able to do this now is because Biden started the process and did 95% of the work for him already It is not flimsy, and there will not be an issue of "future presidents issuing EOs to reverse this" as again, they cannot issue an EO to directly change the scheduling. The only way future presidents change change rescheduling is by ordering a new rescheduling process to begin, which would restart the process that took 4+ years under Biden from scratch.

Tiaan

Well technically the actual rescheduling will have been a 4+ year long administrative process backed by a 252 page HHS report. This EO is just Trump telling his DEA head and AG to issue the final rule and complete the process

Tiaan

Allow me to clarify - presidents cannot issue EOs to reschedule a drug directly. Biden started the currently ongoing process to reschedule cannabis from 1->3 when he issued his EO ordering his departments to look into how it was scheduled back in 2022. That same rescheduling process has been slowly working its way through the administrative channels and has since gotten stuck at the DEA who was against rescheduling under Biden. At this point in the process, all that's left to do is for the DEA head or AG to issue a final rule and then rescheduling is finalized. Trump's executive order on this is going to order his DEA head or AG to finalize the rescheduling that has been ongoing and that's why another president can't just come along and issue an EO to reverse it, because they would need to redo the multi-year long rescheduling process to change it after it gets rescheduled

Shoddy_Ad897

Aight I put money in AG

illinformed-will

For y'all waking up on SLV : HL and AG 👍 you welcome 🤗

alicat0818

Start filing complaints with regulatory agencies. https://www.sec.gov/submit-tip-or-complaint/tcr-disclaimer Investor-complaints.datacollection.finra.org Find your state regulator and file a complaint. State AG is a good place to start. nasaa.org Financial institutions are required to respond to complaints lodged with regulatory agencies in a specific time frame. The response has to follow regulations, so they would have to provide a legal reason why they're withholding your funds. Also, there are requirements around how long an institution can suspend an account while investigating potential fraud. Depending on how long since they were notified that there's no fraud (illegally obtained funds used to create the account as a way to launder the money in your case) they may owe damages for failure to return the money. Use the regulatory agencies to get your money back. The SEC has a whole list of actions against Robinhood they've taken to protect and compensate investors.

Nibbles1348

There is also AG barr for the smaller know British company that makes iron bru etc

Initial-External-709

all these institutions bought HTZ in 2025 * **Pershing Square Capital Management:** Led by billionaire investor Bill Ackman, this firm has made a significant investment in Hertz, holding a stake of nearly 20% in April 2025. * **Knighthead Capital Management, LLC:** Listed as a major shareholder. * **UBS Group AG:** Listed as a major shareholder. * **CIBC Bancorp USA Inc.** * **Cibc World Market Inc.** * **Susquehanna International Group, LLP:** Listed as a major shareholder. * **Cobalt Capital Management, Inc** * **Par Capital Management Inc** * **Gamco Investors, Inc. ET AL** * **Bridgewater Associates, LP** * **Hussman Strategic Advisors Inc** * **Royce & Associates LLC** * **Coatue Management, LLC** * **Graham Capital Management, L.P.** * **SCS Capital Management LLC** * **Steelhead Partners LLC**

Initial-External-709

all these institutions bought HTZ in 2025 recently * **Pershing Square Capital Management:** Led by billionaire investor Bill Ackman, this firm has made a significant investment in Hertz, holding a stake of nearly 20% in April 2025. * **Knighthead Capital Management, LLC:** Listed as a major shareholder. * **UBS Group AG:** Listed as a major shareholder. * **CIBC Bancorp USA Inc.** * **Cibc World Market Inc.** * **Susquehanna International Group, LLP:** Listed as a major shareholder. * **Cobalt Capital Management, Inc** * **Par Capital Management Inc** * **Gamco Investors, Inc. ET AL** * **Bridgewater Associates, LP** * **Hussman Strategic Advisors Inc** * **Royce & Associates LLC** * **Coatue Management, LLC** * **Graham Capital Management, L.P.** * **SCS Capital Management LLC** * **Steelhead Partners LLC**

Initial-External-709

I bought 10.000 shares Today This is heavily shorted due to EPS misses for nearly 1.5 years, and is down near 80%. but Latest Q3 2025 beat the EPS with Positive cash income for the first time. investors: As of early December 2025, major institutional investors in Hertz Global Holdings, institutions hold approximately 99.22% of the company's stock.  institutional investors: * **Pershing Square Capital Management:** Led by billionaire investor Bill Ackman, this firm has made a significant investment in Hertz, holding a stake of nearly 20% in April 2025. * **Knighthead Capital Management, LLC:** Listed as a major shareholder. * **UBS Group AG:** Listed as a major shareholder. * **CIBC Bancorp USA Inc.** * **Cibc World Market Inc.** * **Susquehanna International Group, LLP:** Listed as a major shareholder. * **Cobalt Capital Management, Inc** * **Par Capital Management Inc** * **Gamco Investors, Inc. ET AL** * **Bridgewater Associates, LP** * **Hussman Strategic Advisors Inc** * **Royce & Associates LLC** * **Coatue Management, LLC** * **Graham Capital Management, L.P.** * **SCS Capital Management LLC** * **Steelhead Partners LLC** * **Vanguard Group, Inc.:** Holds 4.42% of the company's shares, with 13.7 million shares as of November 2025. * **BlackRock, Inc.:** Identified as a major shareholder. Short Interest: 54,708,536 shares Float Shorted: 44.31% → Yes, almost half the tradable shares are sold short. Days to Cover: 15.64 → They can’t exit easily. Any spike = trapped. Dark Pool Short Ratio: 64.24% → Translation: they’re hiding shorts off-exchange to mask the selling. This is one of the highest short-interest setups in the entire market right now. Not meme-level “lol maybe squeeze” — this is legit structural pressure. Shorts have committed a massive position, and it’s not something they can just close in an afternoon without blowing the price upward.

Initial-External-709

all these institutions bought HTZ in 2025 * **Pershing Square Capital Management:** Led by billionaire investor Bill Ackman, this firm has made a significant investment in Hertz, holding a stake of nearly 20% in April 2025. * **Knighthead Capital Management, LLC:** Listed as a major shareholder. * **UBS Group AG:** Listed as a major shareholder. * **CIBC Bancorp USA Inc.** * **Cibc World Market Inc.** * **Susquehanna International Group, LLP:** Listed as a major shareholder. * **Cobalt Capital Management, Inc** * **Par Capital Management Inc** * **Gamco Investors, Inc. ET AL** * **Bridgewater Associates, LP** * **Hussman Strategic Advisors Inc** * **Royce & Associates LLC** * **Coatue Management, LLC** * **Graham Capital Management, L.P.** * **SCS Capital Management LLC** * **Steelhead Partners LLC**

Initial-External-709

all these institutions bought HTZ in 2025 * **Pershing Square Capital Management:** Led by billionaire investor Bill Ackman, this firm has made a significant investment in Hertz, holding a stake of nearly 20% in April 2025. * **Knighthead Capital Management, LLC:** Listed as a major shareholder. * **UBS Group AG:** Listed as a major shareholder. * **CIBC Bancorp USA Inc.** * **Cibc World Market Inc.** * **Susquehanna International Group, LLP:** Listed as a major shareholder. * **Cobalt Capital Management, Inc** * **Par Capital Management Inc** * **Gamco Investors, Inc. ET AL** * **Bridgewater Associates, LP** * **Hussman Strategic Advisors Inc** * **Royce & Associates LLC** * **Coatue Management, LLC** * **Graham Capital Management, L.P.** * **SCS Capital Management LLC** * **Steelhead Partners LLC**

Beautiful-Ladder-977

Too late?   Obviously you no very little about AG. 

igotherb

$FFMGF is also a good one. Its close to exiting the permitting phase and Canada is greenlighting everything to boost the economy. The guy who runs it (Keith) has a track record with $AG First majestic silver and $FM.TO First quantum minerals. Easiest buy and hold penny stock for me.

jubilantBeatbox

# Business Overview Biofrontera Inc. (NASDAQ: BFRI) is a **U.S.-based biopharmaceutical company** focused on the **commercialization of prescription therapies for dermatological conditions**, primarily through **photodynamic therapy (PDT)**. The company integrates pharmaceutical products with specialized light-based medical devices to treat skin disorders such as **actinic keratosis (a pre-cancerous condition)** and **impetigo (a bacterial skin infection)**. Its flagship product is **Ameluz**, a topical prescription drug containing aminolevulinic acid, which is used in combination with the **RhodoLED lamp series** for PDT. This combination therapy enables both lesion-directed and field-directed treatment of actinic keratosis on the face and scalp. The company also markets **Xepi**, a topical non-fluorinated quinolone antibiotic for impetigo. In October 2024, Biofrontera completed the **acquisition of U.S. assets related to Ameluz and RhodoLED from Biofrontera AG**, its former parent company, gaining full control over U.S. manufacturing and commercialization rights. This move is expected to improve margins by reducing royalty obligations and enhancing supply chain stability. The company’s business model centers on **direct sales and marketing to dermatologists**, supported by clinical data and reimbursement improvements. It is headquartered in **Woburn, Massachusetts**, and was incorporated in 2015

ivanrybkin

Call options on silver miners! (AG, CDE, Paas etc).

callsonreddit

AG double top? Or avoid puts?

Sad-Depth5258

What a week! The stock market saw some action, and I'm particularly interested in Abaxx Technologies (ABXXF) after a busy week of news. Here's a quick recap of what caught my attention and why I'm adding it to my watchlist for next week. * **CFTC registration**: This is a big one. The U.S. CFTC gave Abaxx Exchange the green light for U.S. futures firms to trade on its non-U.S. markets. This move opens up Abaxx's energy and battery materials futures to a massive new group of investors and traders. Any thoughts on how this could impact liquidity going forward? * **MSCI Small Cap Index inclusion**: Being added to the MSCI Canada Small Cap Index on Monday is a solid vote of confidence and could put the stock on the radar of more institutional funds. I'm keeping an eye on whether this brings increased trading volume next week. * **ARTEX AG partnership**: The announcement of a partnership with ARTEX AG a week ago to modernize digital asset infrastructure also positions Abaxx for further growth. It will be interesting to see how this collaboration develops.  All these catalysts combined made for a strong performance this week. What are your thoughts on ABXXF's long-term potential?

BG-DoG

Well not this particular security, but I picked up a put on AG and IAG. Now I’m hoping to make up my losses in the crypto rebound.

callsonreddit

I figured CLSK and AG would have another +10% day but damn.. I didn't throw in as much $ as I would have liked

callsonreddit

AG +40% this week Goddamm